We develop creatively designed therapeutics that dramatically improve health outcomes for patients suffering from diseases caused by HPV and other viruses.
A Women’s Health Startup Tried to Drum Up Interest for a Much-Deeded Drug. Many Men Didn’t Get It Read article (pdf)
Antiva Biosciences Closes $15 Million Series C-1 Financing Read more
Antiva Biosciences Closes $22 Million Series C Financing Read more